Disposition of meperidine in pregnancy

Plasma concentration‐time profiles of meperidine after intravenous administration to 7 pregnant women during labor were investigated. There was considerable interpatient variation in initial plasma concentrations of meperidine and its volume of distribution. When the data in the literature on the disposition of meperidine in nonpregnant subjects were used for comparison, it was found that the initial dilution volume (V1), the volume of distribution at steady‐state (Vss), and the apparent volume of distribution during the terminal exponential phase of drug elimination (Vβ) were less (p < 0.05) in pregnant subjects than in healthy nonpregnant control subjects but were not significantly different in pregnant subjects and nonpregnant surgical patients. Mean total systemic blood clearance was also significantly less in the pregnant subjects (843 ml/min) than previously reported for healthy nonpregnant control subjects (1,465 ml/min). The blood/plasma concentration ratio of meperidine in pregnant women (0.940) was higher than that in control subjects (0.768; p < 0.01). Placental transfer of meperidine was investigated in 4 of the patients; in 2 the concentration of the drug was greater in cord plasma than in maternal plasma. Further study is indicated.

[1]  G. Tucker,et al.  Systemic availability of orally administered meperidine , 1976, Clinical pharmacology and therapeutics.

[2]  John G. Wagner,et al.  Model-Independent Linear Pharmacokinetics , 1976 .

[3]  L. Lasagna,et al.  Pharmacokinetics of meperidine in man , 1976 .

[4]  Grant R. Wilkinson,et al.  A physiological approach to hepatic drug clearance , 1975 .

[5]  U. Klotz,et al.  The effect of cirrhosis on the disposition and elimination of meperidine in man. , 1975, Clinical pharmacology and therapeutics.

[6]  G. Tucker,et al.  Meperidine kinetics in man; Intravenous injection in surgical patients and volunteers , 1975, Clinical pharmacology and therapeutics.

[7]  G. Wilkinson,et al.  Erythrocyte uptake and plasma binding of di phenyl hydantoin , 1974, Clinical pharmacology and therapeutics.

[8]  T. Mcnabb,et al.  The placental transfer of pentazocine and pethidine. , 1973, British journal of anaesthesia.

[9]  D. Parke,et al.  Effects of pregnancy on the metabolism of drugs in the rat and rabbit. , 1973, Biochemical pharmacology.

[10]  D. Falace,et al.  The distribution and metabolism of Dilantin in non-pregnant, pregnant and fetal rats. , 1970, Archives internationales de pharmacodynamie et de therapie.

[11]  J. S. Crawford,et al.  SOME ALTERATIONS IN THE PATTERN OF DRUG METABOLISM ASSOCIATED WITH PREGNANCY, ORAL CONTRACEPTIVES, AND THE NEWLY-BORN , 1966 .

[12]  L. S. King.  Biostatistics: An Introductory Text , 1964 .

[13]  E. M. Papper,et al.  The physiological disposition and fate of meperidine (demerol) in man and a method for its estimation in plasma. , 1955, The Journal of pharmacology and experimental therapeutics.

[14]  J. J. Curry,et al.  THE ESTIMATION OF HEPATIC BLOOD FLOW IN MAN. , 1945, The Journal of clinical investigation.

[15]  G. Wilkinson.  Pharmacokinetics of drug disposition: hemodynamic considerations. , 1975, Annual review of pharmacology.

[16]  R. Swartz,et al.  Effects of physical stress on the disposition of drugs eliminated by the liver in man. , 1974, The Journal of pharmacology and experimental therapeutics.

[17]  A. Beckett,et al.  Blood concentrations of pethidine and pentazocine in mother and infant at time of birth. , 1967, The Journal of pharmacy and pharmacology.